Glypican 1 and syndecan 1 differently regulate noradrenergic hypertension development: Focus on IP3R and calcium

Simone R Potje1, Ayman Isbatan2, Rita C Tostes3

  • 1Department of Anesthesiology, College of Medicine Tucson, University of Arizona, USA; Department of Anesthesiology, College of Medicine, University of Illinois at Chicago, USA; Department of Pharmacology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil; Department of Physics and Chemistry, Faculty of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Ribeirão Preto, Brazil.

Pharmacological Research
|August 19, 2021
PubMed

Insights

Glypican 1 and syndecan 1 regulate blood pressure. Glypican 1 deficiency protects against hypertension by altering calcium signaling, suggesting it as a therapeutic target.

Area of Science:

  • Cardiovascular Biology
  • Molecular Medicine
  • Hypertension Research

Background:

  • Vascular dysfunction is critical in hypertension development.
  • Heparan sulfate proteoglycans (HSPG) influence nitric oxide (NO) and calcium signaling, vital for vascular function.
  • The roles of HSPG in NO/calcium signaling, vascular dysfunction, and blood pressure regulation remain unclear.

Purpose of the Study:

  • To investigate if HSPGs, specifically syndecan 1 and glypican 1, control systemic blood pressure.
  • To elucidate the mechanisms by which glypican 1 and syndecan 1 regulate vascular tone.
  • To determine their contribution to the development of noradrenergic hypertension.

Main Methods:

  • Systemic arterial blood pressure assessment in knockout mouse models (Sdc1-/- and Gpc1-/-).
  • Evaluation of calcium-dependent vasoconstriction and expression of calcium-sensitive proteins.
  • Analysis of inositol trisphosphate receptor (IP3R) activity and endoplasmic reticulum calcium storage.

Main Results:

  • Both Sdc1-/- and Gpc1-/- mice exhibited decreased systolic blood pressure, notably in Gpc1-/-.
  • Gpc1-/- mice were protected from norepinephrine-induced hypertension.
  • This protection correlated with impaired calcium-dependent vasoconstriction, altered SERCA and calmodulin expression, reduced IP3R activity, and increased ER calcium storage in Gpc1-/- mice.

Conclusions:

  • Glypican 1 acts as a trigger for noradrenergic hypertension via IP3R and calcium signaling pathways.
  • Glypican 1 represents a potential therapeutic target for resistant hypertension.
  • Targeting Glypican 1 may offer new treatment strategies for conditions with elevated norepinephrine.
Abstract

Related Concept Videos

GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
6.2K
IP3/DAG Signaling Pathway01:11

IP3/DAG Signaling Pathway

Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the  phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and...
12.9K
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
3.2K
Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
5.4K
GPCR Desensitization01:12

GPCR Desensitization

G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
6.8K
Neural Regulation of Blood Pressure01:18

Neural Regulation of Blood Pressure

The neural regulation of blood pressure involves intricate interactions between the autonomic nervous system (ANS) and cardiovascular system, ensuring adequate perfusion of tissues. This regulation primarily occurs through baroreceptor and chemoreceptor reflexes, involving both short-term and long-term mechanisms.
Baroreceptor Reflex
Baroreceptors, located in the carotid sinuses and aortic arch, detect changes in blood pressure. When blood pressure rises, these stretch-sensitive receptors...
5.6K